Global Apolipoprotein E Genotype Test Kit Market Growth 2023-2029

Global Apolipoprotein E Genotype Test Kit Market Growth 2023-2029

Apolipoprotein E is an important structural component of particles transporting cholesterol (VLDL, HDL) and is a ligand of cell receptors found mainly in the brain and the liver. The apolipoprotein E gene occurs in three forms of alleles, e2, e3 and e4, which code for protein isoforms E2, E3 and E4 respectively. APOE genotype tests are help understand the role of genetic factors in cardiovascular disease. However, the testing is sometimes used in clinical settings to help confirm a diagnosis of type III hyperlipoproteinemia (also known as familial dysbetalipoproteinemia). The APOE genotype test evaluates a person’s DNA to determine what APOE forms (alleles) are present. APOE e3/e3 is the most common genotype (seen in well over half of the population) and is considered “neutral.” Risks of disease are made relative to the e3/e3 population. APOE e4 (as e4/e4 and e4/e3) is found in nearly a quarter of the population and is associated with an increased risk of atherosclerosis. The e4 allele of the APOE gene has been widely demonstrated to be associated with increased risk of AD. In individuals with a clinical diagnosis of AD, the presence of the e4 allele increases the likelihood that the diagnosis is correct, but is not diagnostic alone. APOE genotyping is not recommended for predicting AD risk in asymptomatic individuals. In this report, we study Apolipoprotein E Genotype Testing, kit and services are covered. Price is the cost of one test.

LPI (LP Information)' newest research report, the “Apolipoprotein E Genotype Test Kit Industry Forecast” looks at past sales and reviews total world Apolipoprotein E Genotype Test Kit sales in 2022, providing a comprehensive analysis by region and market sector of projected Apolipoprotein E Genotype Test Kit sales for 2023 through 2029. With Apolipoprotein E Genotype Test Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Apolipoprotein E Genotype Test Kit industry.

This Insight Report provides a comprehensive analysis of the global Apolipoprotein E Genotype Test Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Apolipoprotein E Genotype Test Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Apolipoprotein E Genotype Test Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Apolipoprotein E Genotype Test Kit and breaks down the forecast by type, by sales channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Apolipoprotein E Genotype Test Kit.

The global Apolipoprotein E Genotype Test Kit market size is projected to grow from US$ 87 million in 2022 to US$ 390.1 million in 2029; it is expected to grow at a CAGR of 390.1 from 2023 to 2029.

Global key players of apolipoprotein e genotype test kit include 23andMe, LabCorp, Empower DX, Mega Genomics, etc. Global top five manufacturers hold a share over 65%. In terms of product, saliva sample is the largest segment, with a share over 77%. And in terms of application, the largest application is online, with a share over 64%.

This report presents a comprehensive overview, market shares, and growth opportunities of Apolipoprotein E Genotype Test Kit market by product type, sales channel, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Blood Sample
Saliva Sample

Segmentation by sales channel
Online
Offline

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
23andMe
LabCorp
Empower DX
Mega Genomics
Blueprint Genetics
Generi-Biotech
RxHomeTest
Kashi Labs
SolGent
CapitalBio
Genex Diagnostics
Sansure

Key Questions Addressed in this Report

What is the 10-year outlook for the global Apolipoprotein E Genotype Test Kit market?

What factors are driving Apolipoprotein E Genotype Test Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Apolipoprotein E Genotype Test Kit market opportunities vary by end market size?

How does Apolipoprotein E Genotype Test Kit break out type, sales channel?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.